Matthew W. Strobeck - 27 May 2022 Form 4 Insider Report for QUIDEL CORP /DE/

Reporting relationship: Director
Issuer ticker: N/A
Reported as of: 27 May 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 01 Jun 2022, 16:27:47 UTC
Prior SEC filing: 26 May 2022
Next SEC filing: 02 Jun 2022
Source filing: View source filing
Reporting owner signature: /s/ Phillip S. Askim, attorney-in-fact for Matthew Strobeck

Key filing fact

Matthew W. Strobeck filed Form 4 for QUIDEL CORP /DE/ on 01 Jun 2022.

Key facts

This page summarizes Matthew W. Strobeck's Form 4 filing for QUIDEL CORP /DE/.
8 reported transactions and 5 derivative rows are listed below.
Accepted by SEC: 01 Jun 2022, 16:27.

Change

Previous filing in this sequence was filed on 26 May 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

QDEL transaction

Common Stock

Disposed to Issuer

Transaction value
Shares: -6,533
Change %: -100%
Price
Shares after: 0
Date: 27 May 2022
Ownership: Direct
Footnotes: F1

QDEL transaction

Common Stock

Disposed to Issuer

Transaction value
Shares: -16,630
Change %: -100%
Price
Shares after: 0
Date: 27 May 2022
Ownership: UGMA Account
Footnotes: F1, F2

QDEL transaction

Common Stock

Disposed to Issuer

Transaction value
Shares: -38,145
Change %: -100%
Price
Shares after: 0
Date: 27 May 2022
Ownership: Birchview
Footnotes: F1, F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

QDEL transaction Derivative

Non-Qualified Stock Options

Disposed to Issuer

Transaction value: $0
Shares: -259
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 27 May 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 259
Exercise price: $53.27
Footnotes: F4, F5

QDEL transaction Derivative

Restricted Stock Units

Disposed to Issuer

Transaction value: $0
Shares: -875
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 27 May 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 875
Exercise price
Footnotes: F6, F7, F8

QDEL transaction Derivative

Restricted Stock Units

Disposed to Issuer

Transaction value: $0
Shares: -262
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 27 May 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 262
Exercise price
Footnotes: F6, F7, F8

QDEL transaction Derivative

Restricted Stock Units

Disposed to Issuer

Transaction value: $0
Shares: -427
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 27 May 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 427
Exercise price
Footnotes: F6, F7, F8

QDEL transaction Derivative

Restricted Stock Units

Disposed to Issuer

Transaction value: $0
Shares: -85
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 27 May 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 85
Exercise price
Footnotes: F6, F7, F8

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Matthew W. Strobeck is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 8 footnotes

Footnote F1

Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation ("Quidel"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement will be exchanged for one share of common stock of QuidelOrtho.

Footnote F2

The Reporting Person is custodian under the Uniform Gift to Minor Act of 16,630 shares held by four of the Reporting Person's children. The Reporting Person disclaims beneficial ownership of these shares, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Footnote F3

The Reporting Person has sole voting and dispositive power with respect to shares held by Birchview Fund, LLC in his capacity as the Chief Executive Officer of such entity. The Reporting Person disclaims beneficial ownership of the shares held by Birchview Fund, LLC except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Footnote F4

Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options will be converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

Footnote F5

Vested in full.

Footnote F6

Each restricted stock unit represents the right to receive one share of Quidel common stock.

Footnote F7

Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

Footnote F8

Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule.